Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Hi-Tech Pharmacal First Quarter Net Income Skids

By Pharmaceutical Processing | September 9, 2013

Hi-Tech Pharmacal said Monday its net income sank in the fiscal first quarter, after it lost a major customer and sales of its generic version of the nasal spray Flonase fell by almost half.

The company said fluticasone sales and prices both decreased, and its revenue from the drug dropped to $11.9 million from $22 million. Overall Hi-Tech’s revenue from generic drugs fell 5 percent. That counteracted improved revenue from its health care product and branded drug businesses.

Hi-Tech Pharmacal Co. said its net income fell to $4.6 million, or 33 cents per share, for the three months ended July 31. That compared with $6 million, or 44 cents per share, in the 2012 fiscal first quarter.

Excluding one-time items, the company said its net income sank to 44 cents per share, from 53 cents per share a year ago. Revenue fell 3 percent, to $50.5 million from $52 million.

Analysts, on average, expected Hi-Tech to report net income of 47 cents per share, on $59 million in revenue, according to FactSet. The company’s fiscal first quarter ended July 31.

Shares of Hi-Tech picked up 9 cents to $43.14 in morning trading. The stock has traded between $28.70 and $44.33 in the past 52 weeks.

Akorn Inc. is in the process of buying Hi-Tech. The companies said on Aug. 27 that Akorn will acquire Hi-Tech for about $640 million, or $43.50 per share. They expect to complete the deal during the first quarter of 2014.

Related Articles Read More >

This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
PHARMAP 2025: Pharma leaders converge in Berlin for fifth anniversary summit
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE